Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool

por Galimberti, Sara, Balducci, Serena, Guerrini, Francesca, Del Re, Marzia, Cacciola, Rossella
Publicado 2022

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

por Del Re, Marzia, Ulivi, Paola, Passardi, Alessandro, Zoli, Wainer, Danesi, Romano, Amadori, Dino
Publicado 2014

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins

por Arrigoni, Elena, Del Re, Marzia, Fidilio, Leonardo, Fogli, Stefano, Danesi, Romano, Di Paolo, Antonello
Publicado 2017

Radiomics and liquid biopsy in oncology: the holons of systems medicine

por Neri, Emanuele, Del Re, Marzia, Paiar, Fabiola, Erba, Paola, Cocuzza, Paola, Regge, Daniele, Danesi, Romano
Publicado 2018

Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

por Ravegnini, Gloria, Del Re, Marzia, Grolla, Ambra A., van Schaik, Ron H. N., Angelini, Sabrina
Publicado 2020

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in pati...

por Del Re, Marzia, Michelucci, Angela, Di Leo, Angelo, Cantore, Maurizio, Bordonaro, Roberto, Simi, Paolo, Danesi, Romano
Publicado 2015

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm

por Banna, Giuseppe Luigi, Cantale, Ornella, Bersanelli, Melissa, Del Re, Marzia, Friedlaender, Alex, Cortellini, Alessio, Addeo, Alfredo
Publicado 2020

The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma

por Janowska, Agata, Iannone, Michela, Fidanzi, Cristian, Romanelli, Marco, Filippi, Luca, Del Re, Marzia, Martins, Manuella, Dini, Valentina
Publicado 2022

Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

por Del Re, Marzia, Di Paolo, Antonello, van Schaik, Ron H., Bocci, Guido, Simi, Paolo, Falcone, Alfredo, Danesi, Romano
Publicado 2010

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

por Del Re, Marzia, Rofi, Eleonora, Cappelli, Carla, Puppo, Gianfranco, Crucitta, Stefania, Valeggi, Simona, Chella, Antonio, Danesi, Romano, Petrini, Iacopo
Publicado 2019

Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol

por Mucherino, Sara, Lorenzoni, Valentina, Orlando, Valentina, Triulzi, Isotta, Del Re, Marzia, Capuano, Annalisa, Danesi, Romano, Turchetti, Giuseppe, Menditto, Enrica
Publicado 2021

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

por Del Re, Marzia, Rofi, Eleonora, Restante, Giuliana, Crucitta, Stefania, Arrigoni, Elena, Fogli, Stefano, Di Maio, Massimo, Petrini, Iacopo, Danesi, Romano
Publicado 2017

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

por Martignano, Filippo, Munagala, Uday, Crucitta, Stefania, Mingrino, Alessandra, Semeraro, Roberto, Del Re, Marzia, Petrini, Iacopo, Magi, Alberto, Conticello, Silvestro G.
Publicado 2021

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy

por Mulder, Tessa A. M., de With, Mirjam, del Re, Marzia, Danesi, Romano, Mathijssen, Ron H. J., van Schaik, Ron H. N.
Publicado 2021

Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment

por Arrigoni, Elena, Del Re, Marzia, Galimberti, Sara, Restante, Giuliana, Rofi, Eleonora, Crucitta, Stefania, Baratè, Claudia, Petrini, Mario, Danesi, Romano, Di Paolo, Antonello
Publicado 2018

erbB in NSCLC as a molecular target: current evidences and future directions

por Del Re, Marzia, Cucchiara, Federico, Petrini, Iacopo, Fogli, Stefano, Passaro, Antonio, Crucitta, Stefania, Attili, Ilaria, De Marinis, Filippo, Chella, Antonio, Danesi, Romano
Publicado 2020

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer

por Del Re, Marzia, Vivaldi, Caterina, Rofi, Eleonora, Vasile, Enrico, Miccoli, Mario, Caparello, Chiara, d’Arienzo, Paolo Davide, Fornaro, Lorenzo, Falcone, Alfredo, Danesi, Romano
Publicado 2017

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Trans...

por Bruno, Rossella, Del Re, Marzia, Cucchiara, Federico, Petrini, Iacopo, Alì, Greta, Crucitta, Stefania, Proietti, Agnese, Valleggi, Simona, Chella, Antonio, Danesi, Romano, Fontanini, Gabriella
Publicado 2021

Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance

por Mascolo, Annamaria, Scavone, Cristina, Ferrajolo, Carmen, Rafaniello, Concetta, Danesi, Romano, Del Re, Marzia, Russo, Antonio, Coscioni, Enrico, Rossi, Francesco, Alfano, Roberto, Capuano, Annalisa
Publicado 2021

CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients

por Crucitta, Stefania, Ruglioni, Martina, Lorenzini, Giulia, Bargagna, Irene, Luculli, Giovanna Irene, Albanese, Irene, Bilancio, Diana, Patanè, Francesca, Fontana, Andrea, Danesi, Romano, Del Re, Marzia
Publicado 2023